financial guidance Agilent Q4 Revenues Rise 12 Percent Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter. NanoString Projects Q4 Instrument Growth; Sees Strong Early Demand for New Spatial Imaging Platform Premium Company executives said that they are seeing high demand for projects involving its forthcoming CosMx spatial molecular imager. Sophia Genetics Q3 Revenues Increase 44 Percent Net loss for the bioinformatics firm, which went public in July, more than doubled year over year during the third quarter to $10.2 million. NanoString Technologies Q3 Revenues Grow 17 Percent The company recorded $37.2 million in total revenues, short of analysts' consensus estimate of $37.8 million. Veracyte Q3 Revenues Nearly Double Total revenues grew to $60.4 million and testing volume for its genomic tests were up 79 percent year over year. Jul 27, 2016 Hologic Q3 Revenues Up 3 Percent Jul 26, 2016 Exact Sciences Revenues More Than Double on Cologuard Sales Jul 25, 2016 Danaher Reports 17 Percent Spike in Q2 Revenues; Restructures Reporting Segments Jun 9, 2016 Luminex Sees Revenue Growth at High End of Guidance; Provides Update on Nanosphere Deal May 18, 2016 Quest Wraps Up Effort to Refocus on Dx Information Services; Lowers 2016 Revenue Guidance May 10, 2016 WaferGen Biosystems Q1 Revenues Up 68 Percent May 6, 2016 CareDx Revenues Drop 8 Percent in Q1 May 3, 2016 UPDATE: Exact Sciences Revenues Up More Than Twofold on Cologuard Sales May 2, 2016 Luminex Q1 Revenues Up 9 Percent Apr 28, 2016 Thermo Fisher Reports Q1 Revenues Up 10 Percent, Raises Full-Year Guidance Apr 28, 2016 Meridian Bioscience Reports Drop in Q2 Revenues, Earnings Apr 27, 2016 Hologic Q2 Revenues Up 6 Percent Mar 8, 2016 Natera Q4 Revenues Rise 6 Percent as Number of Accessioned Tests Balloons 56 Percent Feb 24, 2016 Nanosphere Q4 Revenues Rise 48 Percent Feb 23, 2016 GenMark Diagnostics' Q4 Revenues Rise 34 Percent Feb 18, 2016 MDxHealth Q4 Revenues Rise 68 Percent Feb 2, 2016 Qiagen Q4 Sales Drop 3 Percent on Currency Effects Jan 27, 2016 Meridian Bioscience Q1 Revenues Fall 2 Percent Jan 26, 2016 Danaher Q4 Revenues Rise 13 Percent Jan 11, 2016 Foundation Medicine Expects Sharp Rise in Q4, FY2015 Revenues Load More Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.